- Poster presentation
- Open Access
CKR-L3, a deletion version CCR6-isoform shows coreceptor-activity for limited human and simian immunodeficiency viruses
© Islam et al; licensee BioMed Central Ltd. 2014
- Published: 23 May 2014
We’re sorry, something doesn't seem to be working properly.
Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.
- Chemokine Receptor
- Viral Antigen
- Simian Immunodeficiency Virus
- Immunofluorescence Assay
- Syncytium Formation
Chemokine receptors (CKRs), CCR5 and CXCR4 function as major coreceptors in human/simian immunodeficiency virus (HIV/SIV) infections. About 20 alternative G protein-coupled receptors (GPCRs) have been identified as minor coreceptors for the viruses. We reported CCR6 as an alternative coreceptor. A five-amino acid shorter isoform of CCR6, namely CKR-L3, was examined for its coreceptor function and described in this report.
NP-2 cells transduced with CD4-receptor (NP-2/CD4) normally remain resistant to all HIV/SIV infection; however, further introduction of functional coreceptor can make the cells susceptible to the viruses. NP-2/CD4/CKR-L3 cells were produced to examine coreceptor activity of CKR-L3. Viral antigen in infected NP-2/CD4/coreceptor cells was detected by indirect immunofluorescence assay (IFA). The results were validated by detection of syncytia, proviral DNA and by measuring reverse transcriptase (RT) activities.
HIV-2MIR and SIVsmE660 were found to infect NP-2/CD4/CKR-L3 cells. This justifies the coreceptor function of CKR-L3. Viral antigens appeared faster in NP-2/CD4/CKR-L3 cells than in NP-2/CD4/CCR6, indicates that the CKR-L3 carries more efficient coreceptor-activity. Moreover, syncytia formation was sooner, RT release was higher and earlier through CKR-L3 compared to CCR6. Partial sequence analyses of HIV-2MIR and SIVsmE660 replicated through CKR-L3 and CCR6 coreceptor showed some divergence in envelope region compared to the parental CCR5-variant.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.